GLP-1RA Effects on Lean Mass and Bone Health in Midlife Women

Recruiting Observational Study
Body Composition Muscle Function GLP-1 Estrogen Level
No Placebo Group Every participant receives an active treatment — no one gets a placebo. Healthy Volunteers Welcome You do not need to have the condition being studied to take part. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
35 – 60
Sex
Female
Study type
Observational
Participants needed
50 (estimated)
Sponsor
University of Kansas Medical Center · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

This study is designed with the interest to learn on the effects of estrogen levels and how it affects body compositions and muscle function in midlife women who are taking a GLP-1RA for weight loss.

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Females * Age 35-60 year * BMI≥30 or BMI≥27 and at least one cardiometabolic risk factor (dyslipidemia, hypertension, obstructive sleep apnea, metabolic syndrome, fatty liver, PCOS) * Newly prescribed a GLP-1RA medication * English speaking * Body weight stable for the past 6 …
Contacts

Johanna Finkle, MD

(913) 588-5478

jfinkle2@kumc.edu

CONTACT

Holly Hull, PhD

913-945-5838

hhull@kumc.edu

CONTACT